As of 2025-12-27, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is 79.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.27 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is 362.8%.
The range of the Relative Valuation is 58.42 - 118.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 25.6x | 21.8x |
| Forward P/E multiples | 18.3x - 36.6x | 27.4x |
| Fair Price | 58.42 - 118.79 | 79.92 |
| Upside | 238.3% - 587.8% | 362.8% |
| Date | P/E |
| 2025-12-26 | 5.32 |
| 2025-12-24 | 5.42 |
| 2025-12-23 | 5.39 |
| 2025-12-22 | 5.50 |
| 2025-12-19 | 5.29 |
| 2025-12-18 | 5.31 |
| 2025-12-17 | 5.29 |
| 2025-12-16 | 5.42 |
| 2025-12-15 | 5.53 |
| 2025-12-12 | 5.54 |
| 2025-12-11 | 5.49 |
| 2025-12-10 | 5.19 |
| 2025-12-09 | 4.83 |
| 2025-12-08 | 4.65 |
| 2025-12-05 | 4.42 |
| 2025-12-04 | 4.38 |
| 2025-12-03 | 3.87 |
| 2025-12-02 | 3.77 |
| 2025-12-01 | 4.17 |
| 2025-11-28 | 4.65 |
| 2025-11-26 | 4.58 |
| 2025-11-25 | 4.49 |
| 2025-11-24 | 4.32 |
| 2025-11-21 | 4.21 |
| 2025-11-20 | 4.07 |
| 2025-11-19 | 4.23 |
| 2025-11-18 | 4.15 |
| 2025-11-17 | 4.04 |
| 2025-11-14 | 4.24 |
| 2025-11-13 | 4.13 |
| 2025-11-12 | 3.84 |
| 2025-11-11 | 3.87 |
| 2025-11-10 | 3.79 |
| 2025-11-07 | 3.64 |
| 2025-11-06 | 3.64 |
| 2025-11-05 | 3.31 |
| 2025-11-04 | 3.79 |
| 2025-11-03 | 4.27 |
| 2025-10-31 | 4.58 |
| 2025-10-30 | 4.33 |
| 2025-10-29 | 4.33 |
| 2025-10-28 | 4.69 |
| 2025-10-27 | 4.80 |
| 2025-10-24 | 4.46 |
| 2025-10-23 | 4.35 |
| 2025-10-22 | 4.51 |
| 2025-10-21 | 4.87 |
| 2025-10-20 | 4.94 |
| 2025-10-17 | 4.56 |
| 2025-10-16 | 4.70 |